Title : JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production.

Pub. Date : 2012 Nov

PMID : 22899318






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production. tofacitinib TNF superfamily member 11 Homo sapiens
2 CONCLUSION: These results suggest that the JAK inhibitor tofacitinib suppresses osteoclast-mediated structural damage to arthritic joints, and this effect is secondary to decreased RANKL production. tofacitinib TNF superfamily member 11 Homo sapiens